BI R&D Press Conference "Tomorrow’s Targeted Therapies"
On November 8th 2006, the Boehringer Ingelheim international press conference under the motto "Tomorrow’s Targeted Therapies" took place at the IMP. Its aim was to communicate Boehringer Ingelheim’s research efforts in the field of oncology and present the most promising compounds for future therapies to the media. More than 60 journalists from Europe and Japan participated in the event. The IMP was chosen as location in order to emphasize Boehringer Ingelheim’s strong commitment to basic research. The opportunity to visit labs and talk to the scientists was received very well by the representatives of the media.